James C. Blair, Ph.D.
James C. Blair's Bio
Over the course of his career, James Blair helped shape the success of more than 40 life sciences companies, including Amgen, Applied Biosystems, Amylin Pharmaceuticals and NuVasive. Blair has more than 45 years of experience starting and growing new companies in the life science field, most of which has been accomplished at Domain Associates, the firm he founded in 1985.
In addition to his contributions to Sanford Burnham Prebys, he currently serves on the Board of Directors of Axial Biotherapeutics, ChromaCode, Clovis Oncology, and InflammX Therapeutics. In recent years he has concentrated more effort in not-for-profit activities, having served on the Prostate Cancer Foundation board. In the past, he also served on the advisory boards of the Department of Molecular Biology at Princeton University, the USC Stevens Institute for Innovation, the Caltech Division of Chemistry and Chemical Engineering, and the Department of BioEngineering at the University of Pensylvania.
Blair obtained his doctorate and master’s degrees in electrical engneering from the University of Pennsylvania. He received his bachelor’s degree from Princeton University.
